This inventor holds 2 USPTO granted patents. Top assignees: Mayne Pharma (USA) Inc., Supergen, Inc. Active years: 2006-2007.
Company Filing History:
Years Active: 2006-2007
Title: John Tippett Nelson: Innovator in Graft-Versus-Host Disease Treatment
Introduction
John Tippett Nelson is a notable inventor based in Danville, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of graft-versus-host disease (GVHD). With a total of 2 patents, his work focuses on innovative methods to improve patient outcomes in clinical settings.
Latest Patents
Nelson's latest patents include compositions and methods for treating graft-versus-host disease. These patents provide formulations and dosing regimens of inhibitors of adenosine deaminase (ADA), such as pentostatin. His work emphasizes the prevention and clinical treatment of various forms of GVHD, especially in cases that are steroid-refractory. The methods he developed aim to suppress T-lymphocyte mediated immune responses while minimizing systemic toxicity, making them particularly valuable for organ transplant conditioning.
Career Highlights
Throughout his career, John Tippett Nelson has worked with prominent companies in the pharmaceutical industry. He has been associated with Supergen, Inc. and Mayne Pharma (USA) Inc., where he has contributed to the development of innovative treatments. His expertise in the field has positioned him as a key figure in advancing therapeutic options for patients suffering from GVHD.
Collaborations
Nelson has collaborated with various professionals in his field, including Jorge F DiMartino. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in medical treatments.
Conclusion
John Tippett Nelson's contributions to the treatment of graft-versus-host disease highlight his dedication to improving patient care through innovation. His patents and career achievements reflect a commitment to advancing medical science and providing effective solutions for complex health challenges.